Jessica Martinsson becomes new CEO of SwedenBIO

SwedenBIO has recruited Sprint Biosciences co-founder and COO Jessica Martinsson as its new CEO. She will take up the new role on March 1, 2023.

Jessica Martinsson joins us from Sprint Bioscience where she is a co-founder and where, in addition to her role as COO, she has also been CEO. She is an entrepreneur and drug developer with experience spanning both small and large companies, such as Pharmacia & Upjohn and Biovitrum, and as a board member of Lipigon Pharmaceuticals.

She brings to SwedenBIO her collective knowledge of 27 years in the industry and a master’s degree in chemistry from Uppsala University.

“I am very pleased that Jessica Martinsson will be the new CEO of SwedenBIO”, says Lotta Ljungqvist, chair of the organization’s board.

“With her experience as an entrepreneur and co-founder of life science companies, SwedenBIO gets a leadership that will drive the industry’s development further. Jessica’s knowledge in pharmaceutical development in both small and large companies and her passion for collaboration will create better conditions for the industry – which is needed to improve public health and society at large in the long run”, says Ljungqvist.

About taking office in March, Jessica Martinsson says: “For me, SwedenBIO is an organization with great value for our member companies and I am very proud to have the opportunity to lead the continued development. Together with a competent team at the secretariat and a strong board, SwedenBIO will become an even clearer voice in the public debate”.

Read the press release.